
Sanofi-Aventis to invest in R&D in Spain
Business Investments
01 Apr 2012
France-based pharmaceutical company Sanofi-aventis plans to invest $1.3 million in research and development (R&D) projects of Barcelona's international biomedical research institute CRG.
The projects include cell reprogramming, the application of synthetic biology technology to treat lung diseases, the influence of genes as factor for some diseases and tuberculosis treatment, the director of CRG, Luis Serrano, said.
Source: IPA WORLD, 8/3/2012
Related News and Success stories.
-
20 May 2025
NTT DATA launches Living Lab, a new innovation and co-creation center in Barcelona
-
14 May 2025
North American AI leader CoreWeave launches new data center in Barcelona
-
07 May 2025
Barcelona, named Europe’s 4th Best City in 2025
-
23 Apr 2025
Multinational company Sanofi will open an innovation center in Barcelona, creating 300 jobs